M. Guillermier

Type de document

Co-auteur

F. Petit

P. Hantraye

N. Dufour

N. Deglon

E. Brouillet

D. Houitte

L. Galvan

C. Jan

M.C. Gaillard

L. Francelle

M. De Chaldée

G. Bonvento

G. Auregan

J. Valette

L. Stimmer

F. Saudou

A.L. Perrier

K. Merienne

C. Malgorn

S. Luccantoni

G. Liot

C. Joséphine

M. Jarrige

S. Humbert

J. Flament

J.M. Elalouf

E. Diguet

A. Delzor

T. Delzescaux

L. de Longprez

M. Damiano

D'Aurelio, M.

M.A. Carrillo-de Sauvage

J.M. Canals

K. Cambon

L. Benhaim

A.P. Bemelmans

M.F. Beal

J. Alberch

Date

Source

Serveur académique Lausannois (4)

Mot-clé

protéine (4) Expression (4) mutant (3) Neurons (3) Mice (3) Huntington's disease (3) Example (3) Brain (3) cerveau (3) spectacle (2) neurotoxicité (2) modèle (2) perte (2) analyse (2) règlement (2) Genes (2) Neurotoxicology (2) Transcription (2) Rats (2) Proteins (2) Play (2) Patients (2) Hypothesis (2) Degeneration (2) Animals (2) Regulation (2) Analysis (2) Transcription (2) Patients (2) Models (2)

Documents écrit par M. Guillermier (4) | parle de M. Guillermier (9)

The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin.

L. Galvan et al. (1 mai 2018)

Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease.

L. Francelle et al.

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.

M. Damiano et al. (2013)

Restricted transgene expression in the brain with cell-type specific neuronal promoters.

A. Delzor et al. (2012)